Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Non-Current Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Non-Current Liabilities for 3 consecutive years, with $89.6 million as the latest value for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 5.05% to $89.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $89.6 million through Jan 2026, up 5.05% year-over-year, with the annual reading at $90.2 million for FY2025, 15.43% up from the prior year.
  • Total Non-Current Liabilities for Q1 2026 was $89.6 million at Kestra Medical Technologies, up from $82.5 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $90.2 million in Q2 2025, with the low at $76.9 million in Q3 2025.
  • Average Total Non-Current Liabilities over 3 years is $83.8 million, with a median of $83.9 million recorded in 2025.
  • The sharpest move saw Total Non-Current Liabilities rose 15.43% in 2025, then rose 5.05% in 2026.
  • Over 3 years, Total Non-Current Liabilities stood at $78.1 million in 2024, then grew by 5.55% to $82.5 million in 2025, then grew by 8.64% to $89.6 million in 2026.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $89.6 million, $82.5 million, and $76.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.